US equities
|
SPCX
$168.93
▲+6.27%
NVDA
$237.88
▲+1.68%
MU
$1,063.62
▼-1.05%
TSLA
$379.64
▲+2.44%
MSFT
$525.26
▲+1.49%
SNDK
$1,713.61
▼-0.37%
INTC
$117.14
▼-1.84%
META
$744.04
▲+2.19%
SPCX
$168.93
▲+6.27%
NVDA
$237.88
▲+1.68%
MU
$1,063.62
▼-1.05%
TSLA
$379.64
▲+2.44%
MSFT
$525.26
▲+1.49%
SNDK
$1,713.61
▼-0.37%
INTC
$117.14
▼-1.84%
META
$744.04
▲+2.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Mind Medicine Inc
MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress
October 03, 2023
From
Mind Medicine Inc
Via
Business Wire
Tickers
MNMD